跳至主要内容
临床试验/NCT04185272
NCT04185272招募中不适用

Role of Butyrophilins in Colon Cancers Aggressiveness Evaluation

Institut Paoli-Calmettes1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2020年6月30日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
200
试验地点
1
主要终点
evaluation of BTNL3, BTNL8 and BTNL9 expression by transcriptomics and immunohistochemistry

研究概览

简要总结

quantification of BTNL molecules in colon cancer in order to determinate if their could be used as a prognostic marquer

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Basic Science
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient is older than 18 years old,
  • Signed participation consent,
  • Non-metastatic colon cancer immediately resectable or metastatic and liver synchronous for which it was decided a combined colic and liver surgery (metastatic patient at the outset) in multidisciplinary consultation meeting.
  • Performance Status (PS) 0 or 1
  • affiliated to the social security or beneficiary

排除标准

  • Rectal cancer, colon cancer recurrence
  • Emergency of colon cancer Surgery
  • History of inflammatory disease of the digestive tract (Crohn's disease or ulcerative colitis)
  • Patient who received neoadjuvant therapy other than chemotherapy
  • Patient treated with immune-suppressors or long-course corticosteroids <12 months
  • Pregnant women or likely to be pregnant (without effective contraception) or breastfeeding,
  • Person in urgent situation, person under legal protection measure, or unable to express his / her consent,
  • Impossibility of submitting to the medical examination of the test for geographical, social or psychological reasons

研究组 & 干预措施

non-metastatic colon cancer

Experimental

干预措施: analysis of BTN and BTNL status (Biological)

metastatic colon cancer

Experimental

干预措施: analysis of BTN and BTNL status (Biological)

结局指标

主要结局

evaluation of BTNL3, BTNL8 and BTNL9 expression by transcriptomics and immunohistochemistry

时间窗: 8 years

healthy and cancerous colon ad metastasis (if applicable) will be analysed by

次要结局

未报告次要终点

研究者

发起方
Institut Paoli-Calmettes
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验